Guinea-Bissau vs Iran: The number of people with susceptibility test result for rifampicin
Guinea-Bissau
1,934
in 2021
Iran
1,828
in 2021
Guinea-Bissau rank
48th
Iran rank
51st
The number of people with susceptibility test result for rifampicin over time
- Guinea-Bissau
- Iran
How they compare
Guinea-Bissau currently reports 1,934 against 1,828 in Iran, a difference of 106.
That makes Guinea-Bissau's figure about 1.1 times Iran's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Iran ahead.
Guinea-Bissau ranks 48th and Iran ranks 51st of 155 countries.
Iran has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20.67 | 3,008 | 2,988 | Iran |
| 2020s | 1,573 | 1,608 | 34.5 | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guinea-Bissau or Iran?
- Guinea-Bissau, at 1,934 against 1,828 in Iran as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guinea-Bissau and Iran?
- 106, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Iran?
- 5 years are reported by both, from 2017 to 2021.
- How do Guinea-Bissau and Iran rank globally for the number of people with susceptibility test result for rifampicin?
- Guinea-Bissau ranks 48th and Iran ranks 51st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.